Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.
Bezjak A, Tu D, Seymour L, Clark G, Trajkovic A, Zukin M, Ayoub J, Lago S, de Albuquerque Ribeiro R, Gerogianni A, Cyjon A, Noble J, Laberge F, Chan RT, Fenton D, von Pawel J, Reck M, Shepherd FA; National Cancer Institute of Canada Clinical Trials Group Study BR.21.
Bezjak A, et al. Among authors: laberge f.
J Clin Oncol. 2006 Aug 20;24(24):3831-7. doi: 10.1200/JCO.2006.05.8073.
J Clin Oncol. 2006.
PMID: 16921034
Clinical Trial.